Effects of Aspirin on the in vitro and in vivo acetylation of 2-aminofluorene in Sprague-Dawley rats

In Vivo

Volumn 19, Issue 2, 2005, Pages 475-482

  Lin, Song Shei ^a   Yu, Chun Shu ^b   Wu, Jeng Yuan ^c   Tyan, Yeu Sheng ^d   Hsia, Te Chun ^e   Lin, Wen Chun ^b   Chung, Jing Gung ^b  

^a CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2 aminofluorene; Acetylsalicylic acid; N acetyl 2 aminofluorene; N acetyl p aminobenzoic acid; N acetyltransferase; P aminobenzoic acid

Indexed keywords

2 FLUORENYLAMINE; ACETYLSALICYLIC ACID; ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; N (2 FLUORENYL)ACETAMIDE;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG CLEARANCE; DRUG DISPOSITION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CYTOSOL; MALE; NONHUMAN; RAT;

EID: 16344383100     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Miller EC and Miller JA: Search for the ultimate chemicals carcinogens and their reaction with cellular macromolecules. Cancer 47 2327-2345, 1981.
2. Lower GM: Concepts in causality; chemically induced human urinary bladder cancer. Cancer 49: 1056-1066, 1982.
3. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25-79, 1985.
4. Weber WW: The Acetylator Genes and Drug Response, Oxford University Press, New York: pp 21-55, 1987.
5. Chung JG, Levy GN and Weber WW: Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Metab Dispos 21: 1057-1063, 1993.
6. Wu HC, Lu HF, Hung CF and Chung JG: Inhibition by vitamin C of adduct formation and arylamine N-acetyltransferase activity in human bladder tumor cells. Urol Res 28: 235-241, 2000.
7. Ho CC, Lin TH, Lai YS, Chung JG, Levy GN and Weber WW: Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Meta Dispos 24: 137-141, 1996.
8. Ho CC, Chung JG, Lee JH, Lai JM, Shih MC, Lai YS and Hung CF: Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator fish tissues. Environ Toxicol Chem 69: 469-479, 1999.
9. Chung JG, Kuo HM, Lin TH, Ho CC, Lee JH, Lai JM, Levy GN and Weber WW: Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Lett 106: 1-8, 1996.
10. Chung JG, Wang HH, Tsou MF, Hsien SE, Lo HH, Yen YS, Chang SS, Wu LT, Lee JH and Hung CF: Evidence for arylamine N-acetyltransferase in the bacteria Helicobacter pylori. Toxicol Lett 91: 63-71, 1997.
11. Hung CF, Huang DS and Chung JG: Kinetics of acetyl CoA: arylamine N-acetyltransferase from human placeta. Res Commun Pharmacol Toxicol 2: 105-119, 1997.
12. Chung JG, Kuo HM, Wu LT, Lai JM, Lee JH and Hung CF: Evidence for arylamine N-acetyltransferase in Hymenolepis nana. Chinese J Microbiol Immunol 30: 1-17, 1997,
13. Tannen RH and Weber WW: Inheritance of acetylator phenotype in mice. J Pharm Exp Thera 213: 480-484, 1980.
14. Hein DH, Omichinski JG, Brewer JA and Weber WW: A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharm Exp Thera 220: 8-15, 1982.
15. Ilett KK, David BM, Detchon P, Castledon WM and Kwa R: Acetylator phenotype in colorectal carcinoma. Cancer Res 47: 1466-1469, 1987.
16. Lang NP, Chu DZJ, Hunter CF, Kendell DC, Flammang JJ and Kadlubar F: Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-1261, 1987.
17. Cartwright RA, Glasham RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins and Kaha MA: The role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842-846, 1982.
18. Einisto P, Watanabe M, Ishidate M and Nohmi T: Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res 259: 95-102, 1991.
19. Mannering GJ and Deloria LB: The pharmacology and toxicology of the interferons: an overview. Annu Rev Pharmacol Toxicol 26: 455-515, 1986.
20. Renton KW and Mannering GJ: Depression of hepatic cytochrome P-450-dependent monooxygenase system with administered interferon inducing agents. Biochem Biophys Res Commun 73: 343-347, 1976.
21. DuSouich P and Courteau H: Induction of acetylation capacity with complete Freund's adjuvant and hydrocortisone in the rabbit. Drug Metab Dispos 9: 279-283, 1981.
22. Svensson CK and Knowlton PW: Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat. Pharmaceutical Res 6: 477-450, 1989.
23. Binder M and Zeiller P: Antiphlogistic effect of salicyclic acid and its derivatives. [German]. Fortschritte der Medizin 111: 530-532, 1993.
24. Darius H and Meyer J: Acetylsalicyclic acid in unstable angina, after coronary revascularization and in prevention of cardiac thromboembolism. [German]. Zeitschrift fur Kardiologie 81 Suppl. 4: 177-184, 1992.
25. Schroder H and Schror K: Clinical pharmacology of acetylsalicyclic acid. [German]. Zeitschrift fur Kardiologie 81 suppl 4: 171-175, 1992.
26. Daigneault EA, Hamdy RC, Ferslew KE, Rice PJ, Singh J, Harvill LM and Kalbfleisch JH: Investigation of the influence of acetylsalylic acid on the steady state of long-term therapy with theophylline in elderly male patients with normal renal function. J Clin Pharmacol 34: 86-90, 1994.
27. Weber WW, Radtke HE and Tannen RH: Extrahepatic N-acetyltransferase and N-deacetylases. In: Extrahepatic Metabolism of Drugs and Other Foreign Compounds (Gram TE ed.), pp 493-531 NY: Spectrum Publications, Jamarica, 1980.
28. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
29. Cleland WW: The statistical analysis of enzyme kinetics data. Adv Enzymol 29: 1-30, 1967.
30. Levy GN and Weber WW: 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex, and acetylator phenotype. Carcinogenesis 13: 159-164, 1982.
31. Nerurkar PV, Schut HAJ, Anderson LM, Riggs CW, Snyderwine EG, Thorgiersson WW, Weber WW, Rice JM and Levy GM: DNA adducts of 2-amino-3-imidazo[4,5-f]quinoline (IQ) in bladder, colon, and kidney of congenic mice differing in ah-responsiveness and N-acetyltransferase genotype. Cancer Res 55: 3043-3049, 1985.
32. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophys Res Commun 185: 839-844, 1982.
33. Grant DM, Josephy PD and Lord HL: Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: metabolism and mutagenic activation of aromatic amines. Cancer Res 52: 3961-3964, 1992.
34. Larsen GL: Deconjugation of biliary metabolites by microfloral β-glucuronidase, sulphatase and cysteine conjugate β-lyase and their subsequent enterohepatic circulation. In: Rowland I (ed.), Role of Gut Flora in Toxicity and Cancer, pp 79-107, London: Academic Press, 1988.
35. Peterson TC and Renton KW: Kupffer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450. Biochem Pharmacol 35: 1491-1497, 1986.
36. Zidek Z, Friebova M, Janku I and Elis J: Influence of sex and Freund's adjuvant on liver N-acetyltransferase activity and elimination of sulphadimidine in urine of rats. Biochem Pharmacol 26: 69-70, 1981.
37. Reeves PT, Minchin RF and Ilett KF: Induction of sulfamethazine acetylation by hydrocortisone in the rabbit. Drug Metab Dispos 16: 110-115, 1988.